XML 29 R19.htm IDEA: XBRL DOCUMENT
v3.10.0.1

Balance Sheet Components (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2018
Organization Consolidation And Presentation Of Financial Statements [Abstract] |
Schedule of Cash and Cash Equivalents | Cash and cash equivalents consisted of the following (in thousands):
|  | September 30, 2018 |  |  | December 31, 2017 |
Cash |  | $ | 71,591 |  |  | $ | 103,716 |
Money market funds |  |  | 495,131 |  |  |  | 569,942 |
Total cash and cash equivalents |  | $ | 566,722 |  |  | $ | 673,658 |
Summary of Amortized Cost, Gross Unrealized Holding Gains or Losses, and Fair Value of Available-for-Sale Investments | The Company’s investments consist of available-for-sale debt investments and marketable equity investments. The amortized cost, gross unrealized holding gains or losses, and fair value of the Company’s available-for-sale investments by major investments type are summarized in the tables below (in thousands):
|  | September 30, 2018 |
|  | Amortized Cost |  |  | Gross Unrealized Holding Gains |  |  | Gross Unrealized Holding Losses |  |  | Fair Value |
Corporate bonds |  | $ | 6,011 |  |  | $ | — |  |  | $ | (2 | ) |  | $ | 6,009 |
Certificate of deposits |  |  | 110,000 |  |  |  | — |  |  |  | (67 | ) |  |  | 109,933 |
Bond and mutual funds |  |  | 10,399 |  |  |  | 47 |  |  |  | — |  |  |  | 10,446 |
Equity investments |  |  | 125 |  |  |  | 98 |  |  |  | — |  |  |  | 223 |
Total investments |  | $ | 126,535 |  |  | $ | 145 |  |  | $ | (69 | ) |  | $ | 126,611 |
|  | December 31, 2017 |
|  | Amortized Cost |  |  | Gross Unrealized Holding Gains |  |  | Gross Unrealized Holding Losses |  |  | Fair Value |
Corporate bonds |  | $ | 53,985 |  |  | $ | 4 |  |  | $ | (46 | ) |  | $ | 53,943 |
Bond and mutual funds |  |  | 17,249 |  |  |  | 1,153 |  |  |  | — |  |  |  | 18,402 |
Equity investments |  |  | 126 |  |  |  | 95 |  |  |  | — |  |  |  | 221 |
Total investments |  | $ | 71,360 |  |  | $ | 1,252 |  |  | $ | (46 | ) |  | $ | 72,566 |
Schedule of Accrued Liabilities | Accrued liabilities consisted of the following (in thousands):
|  | September 30, 2018 |  |  | December 31, 2017 |
Preclinical and clinical trial accruals |  | $ | 22,606 |  |  | $ | 32,321 |
Payroll and related accruals |  |  | 16,626 |  |  |  | 18,810 |
Property taxes and other |  |  | 1,900 |  |  |  | 4,201 |
Professional services |  |  | 1,835 |  |  |  | 1,991 |
Other |  |  | 9,631 |  |  |  | 6,458 |
Total accrued liabilities |  | $ | 52,598 |  |  | $ | 63,781 |

X
- References No definition available. + Details
Name: | us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of accrued liabilities. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the reconciliation of available-for-sale securities from cost basis to fair value. + References No definition available. + Details
Name: | us-gaap_ScheduleOfAvailableForSaleSecuritiesReconciliationTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the components of cash and cash equivalents. + References No definition available. + Details
Name: | us-gaap_ScheduleOfCashAndCashEquivalentsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration